Sodium Acetate NDC 0409-3299

NDC codes

FDA NDC Directory

Product NDC (as listed)0409-3299Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00409-3299Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0409-3299-05	00409329905	25 VIAL in 1 TRAY (0409-3299-05) / 50 mL in 1 VIAL (0409-3299-15)Marketed from May 16, 2005
0409-3299-06	00409329906	25 VIAL in 1 CASE (0409-3299-06) / 100 mL in 1 VIAL (0409-3299-16)Marketed from Apr 30, 2005

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Acetate
Generic name (nonproprietary): sodium acetate
Active ingredients: Sodium acetate anhydrous — 164 mg/mL
Dosage form: Injection, Solution, Concentrate
Route: Intravenous
Labeler: Hospira, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 018893
Marketing start: Apr 30, 2005
Listing expires: Dec 31, 2027
Identifiers: Product ID 0409-3299_4e6137c2-6b7c-4882-985c-03b591b6c046SPL ID 4e6137c2-6b7c-4882-985c-03b591b6c046SPL set ID abc41ed1-9512-4bea-9295-1a9ca134b6c2RxCUI 237371UNII NVG71ZZ7P0

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400409329905 followed by a unit qualifier and the quantity

Package 00409-3299-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 26, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Sodium Acetate Injection, USP (2 mEq/mL) is indicated as a source of sodium for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 018893

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 018893
Product	Strength	Form · route	Labeler	Product NDC
Sodium Acetate	Sodium acetate anhydrous 3.28 g/20mL	Injection, Solution, ConcentrateIntravenous	Hospira, Inc.	0409-7299
Sodium Acetate	Sodium acetate anhydrous 3.28 g/20mL	Injection, Solution, ConcentrateIntravenous	Hospira, Inc.	0409-7299